Skip to content

Myeloperoxidase IgG Antibodies, Serum or Plasma

Published: August 9, 2026Updated: August 16, 2026

This test looks for IgG antibodies directed against myeloperoxidase (MPO), an enzyme found in certain white blood cells. These antibodies can be a marker of certain autoimmune conditions affecting small blood vessels.

Quick summary

["An MPO IgG antibody result is interpreted alongside your symptoms and other tests, and it is not a diagnosis on its own."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
108860-8
Short code
Myeloperoxidase IgG Msmt SerPl
Synonyms
Myeloperoxidase IgG Msmt SerPl
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
CPT
82784
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

What Is Being Measured

Myeloperoxidase (MPO) is an enzyme stored in a type of white blood cell called neutrophils. This test measures IgG-class antibodies that bind to MPO. The specimen is serum or plasma, and the result is reported from an immunoassay method.

Why Your Clinician May Order It

This test is often ordered when an autoimmune inflammation of small blood vessels (vasculitis) is suspected, or to help monitor a known condition. It may be part of a panel that also includes other antibody tests.

How the Test Is Done

A blood sample is collected from a vein, usually in your arm, and sent to the laboratory. There is no special preparation required unless your clinician gives other instructions.

How to Understand Your Result

Results are usually reported as positive, negative, or with a numeric level, depending on the laboratory. A positive result does not by itself mean you have a disease, and a negative result does not always rule one out. Your clinician interprets the result together with your symptoms, physical exam, and other laboratory findings.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

MPO IgG antibodies are associated with certain forms of small-vessel vasculitis and can also appear in other inflammatory or autoimmune conditions, and sometimes at low levels in people without disease. Because of this, the test is used as one piece of a broader clinical picture rather than as a stand-alone diagnosis.

Short name

MPO IgG Antibody

Frequently asked questions

Does a positive MPO antibody result mean I have vasculitis?
Not necessarily. A positive result can support the possibility of vasculitis when other findings fit, but it can also occur in other conditions or at low levels without disease. Your clinician will consider your symptoms and other test results.
Do I need to fast before this test?
Fasting is generally not required for this antibody test. Follow any specific instructions your clinician or laboratory provides.
Can the result change over time?
Yes. Antibody levels can change, and repeat testing may be used to help monitor your condition. Your clinician will decide whether and when repeat testing is appropriate.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy